Lexeo Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Lexeo Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Lexeo Therapeutics Inc.
Rating: 0.87683325
Author: Trendlyne DVM scores

about

Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on ...

4.55 -0.14 (-2.99%)

58.60% Fall from 52W High

415.0K

XNAS Volume

XNAS 20 Jul, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

11.3 / 100

Technically Bearish

23.7 / 100

No estimates available

Lexeo Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Lexeo Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases. The company is advancing a portfolio of programs focused on ...

58.60% Fall from 52W High

SWOT Analysis

Lexeo Therapeutics Inc Live Price Chart

Lexeo Therapeutics Inc Live Price Chart